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ABSTRACT
PHYSICAL FRAILTY AND WHITE MATTER ABNORMALITIES: THE ARIC
STUDY
Emma L. Ducca

Physical frailty is associated with increased risk for dementia and other
neurologic sequelae. However, the neurobiological changes underlying frailty and frailty
risk remain unknown. The association of cerebral white matter structure with current and
future frailty was examined. Atherosclerosis Risk in Communities Study Neurocognitive
Study participants who underwent 3T brain MRI were included. Frailty status was
classified according to the Fried criteria. Cerebral white matter integrity was defined
using white matter hyperintensity (WMH) volume and microstructure, measured using
diffusion tensor imaging fractional anisotropy (FA) and mean diffusivity (MD).
Multivariable linear regression was used to relate baseline frailty to white matter
structure; multivariable logistic regression was used to relate baseline white matter to
frailty risk among participants non-frail at baseline. In the cross-sectional analysis
(N=1,754; mean age: 76 years) frailty was associated with greater WMH volume, lower
FA, and greater MD. These associations remained consistent after excluding participants
with history of stroke or dementia. Among participants non-frail at baseline who
completed follow-up frailty assessment (N=1,379; 6.6-year follow-up period), each
standard deviation increase in WMH volume was associated with 1.46 higher odds of
frailty at follow-up. Composite FA and MD measures were not associated with future

frailty; however, secondary analyses found several significant white matter tract-specific
associations with frailty risk. The current study demonstrates a robust association of
WMH volume with current and future frailty. Although measures of white matter
microstructure were altered in frail individuals, these measures were not generally
associated with progression from frail to non-frail status.
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Introduction
Frailty is a complex health condition in older adults that results in diminished
physiologic reserve due to the decline in functioning across multiple physiologic systems
(Fried et al., 2001). Estimates of frailty and prefrailty prevalence among communitydwelling older adults (i.e., aged 65 and older) varies widely from 4.9-27.3% to 34.650.9% (Choi et al., 2015). Frailty is associated with increased vulnerability to health
sequelae including falls, disability, chronic illness, increased health care utilization, and
premature death (X. Chen et al., 2014; Kanapuru & Ershler, 2009). Increased healthcare
utilization and disability among frail individuals are associated with increased healthcare
costs and represent significant economic burden for these individuals and our greater
society (Bock et al., 2016). Large population studies have found that frailty is associated
with subjective measures of poor health (i.e., depressive symptoms, self-reported poor
health, low medication adherence) in addition to elevated biomarkers of inflammation
and hyperglycemia (i.e., hemoglobin A1c, white blood cell count, and C-reactive protein)
and poorer cardiovascular health (i.e., hemoglobin, total cholesterol) (Kucharska-Newton
et al., 2017).
Frailty is characterized by individuals experiencing maladaptive responses to
physiological stressors, often resulting in declines in overall health and reduced
functional independence (X. Chen et al., 2014). The existing literature suggests chronic
systemic inflammation, as measured by blood inflammatory markers, may be a key factor
in frailty pathogenesis independent of medical comorbidities (Soysal et al., 2016; Walker
et al., 2019). However, the precise mechanisms driving this relationship remain unclear
and multiple physiologic pathways may be involved. One hypothesis is that chronic,
sustained inflammation may result in excessive “wear and tear” which over time
1

increases vulnerability to stressors, while others suggest that inflammation is a biproduct
of underlying disease processes (Franceschi & Campisi, 2014).
Frailty frequently coexists with neurologic disease including cerebrovascular
disease and dementia (Kulmala et al., 2014; Palmer et al., 2019). Furthermore, there is
evidence to suggest that frailty may contribute to cognitive decline and development of
neurodegenerative brain changes (Buchman et al., 2007; Wallace et al., 2020). There is
some conflicting evidence regarding the etiopathogenesis of these conditions. To
elaborate, frailty appears to increase risk for overall cognitive and functional decline as
well as Alzheimer’s disease (AD) and vascular neurocognitive disorders (Boyle et al.,
2010; Gray et al., 2013; Solfrizzi et al., 2013; Kojima et al., 2016). Contrastingly, other
studies suggest that cognitive impairment may increase risk for developing frailty (Doba
et al., 2012; Gross et al., 2016; Raji et al., 2010). Taken together, these results suggest
that frailty and neurodegenerative conditions may be bidirectional or have shared
etiologies.
Neuroimaging studies provide insight into the underlying neural correlates of
frailty. Although there is considerable evidence suggesting that frailty and pathological
aging are connected, there is some conflicting evidence regarding the etiological origins
of these conditions. As noted above, physical frailty prevalence has been linked to
development of several neurodegenerative diseases. However, there is evidence
suggesting that brain changes implicated the development of neurodegenerative diseases
may also promote physical frailty (Dobryakova et al., 2013; Wennberg et al., 2017). That
is, patients with age-related pathology in subcortical gray matter structures and frontal
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cortex often demonstrate many of the physical frailty criteria including slowed gait speed,
fatigue, and exhaustion as well as cognitive fatigue.
Cerebral white matter abnormalities are associated with cognitive decline and
dementia (Hahn et al., 2013; Knopman et al., 2015) as well as frailty (Chung et al., 2016;
Avila-Funes et al., 2017; Del Brutto et al., 2017; Siejka et al., 2018). However, results
have been somewhat inconsistent. A 2018 review of neuroimaging studies examining
frailty and its components found only 17 studies (n = 979 records identified) which
examined neuroimaging correlates of frailty among an older adult population. Results
consistently showed associations between frailty and its components (gait speed and grip
strength) and measures of white matter disease (López-Sanz et al., 2018). The existing
literature suggests that there is a relationship between physical frailty and cerebrovascular
abnormalities including increased presence of infarcts, WMH, and other measures of
cerebral small vessel disease (Kant et al., 2018, 2019).
Although a number of studies have demonstrated that frailty is associated with
increased levels of cerebral white matter abnormalities, the existing evidence on the
relationship between white matter abnormalities and frailty progression is limited, with
only three studies identified to date (Avila-Funes et al., 2017; X. Chen et al., 2014; Choi
et al., 2015; Fried et al., 2001; Kant et al., 2019; López-Sanz et al., 2018; Newman et al.,
2001; Siejka et al., 2018; Tian et al., 2020). Two such investigations found that baseline
WMH volume was associated with progression of frailty symptoms, but not frailty
incidence (Maltais et al., 2019; Siejka et al., 2020). One other study has examined white
matter microstructural integrity and frailty incidence (Maltais et al., 2020). Results of this
investigation suggested that progression of frailty symptoms was associated with
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increased diffusivity among specific white matter tracts. However, this relationship did
not extend to other indicators of white matter integrity (i.e., fractional anisotropy [FA]).
Thus, while frailty and white matter disease appear to be related, it remains unclear
whether white matter abnormalities are associated with risk of future frailty and whether
these associations differ across the spectrum of cognitive impairment.
Using a large community- based sample of Black and White older adults, the
present study examined the association of WMH volume and white matter
microstructural integrity with current frailty status and future frailty status across a 7-year
follow-up period. The following hypotheses were proposed:
(1) Participants who were frail at baseline would have increased evidence of white
matter disease on neuroimaging as compared to non-frail participants.
(2) Participants with greater white matter disease on neuroimaging at baseline
would be more likely to convert to frailty as compared to participants with lower
white matter disease.
Given the potential influence of neurodegenerative disease on the white matter frailty relationship, the effect of cognitive status was examined using stratified analyses.
Race and sex were examined as effect modifiers given the existing literature
demonstrating racial and sex disparities in cardiovascular health, and the increased
prevalence of cerebrovascular disease among Black participants (Nyquist et al., 2014).
We predicted that the effect of white matter disease on frailty would be moderated by
self-identifying as Black and female sex.
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Methods
Study design and participants
The ARIC study is an ongoing, community based prospective cohort study. For
the initial visit (1987-89) 15,792 participants ages 45-65 were recruited from four
communities within the Washington County, MD; Forsyth County, NC; northwestern
suburbs of Minneapolis, Minnesota; and Jackson, Mississippi. Of the 6,528 participants
who attended ARIC Visit 5, 1,978 participants completed 3T brain MRI. Participant
selection criteria are outlined below and are outlined in Knopman (2015). Briefly,
participants with known MRI contraindications were excluded. MRI selection criteria
included if they completed a brain MRI as part of the ARIC Brain MRI Ancillary Study
in 2004-2006 or, demonstrated cognitive impairment. Cognitive impairment was defined
as either a low Mini Mental Status Exam (MMSE) score (<21 for White participants and
<19 for Black participants), or impairment on two or more cognitive domain scores at
Visit 5 (<-1.5 standard deviations) and decline on the Delayed Word Recall test, Digit
Symbol Substitution test, or Word Fluency test (Visit 5 score minus highest previous
score <10th percentile on 1 or more tests or <20th percentile on 2 or more tests). An
additional sample of cognitively intact participants with an age distribution that
approximated that of the cognitively impaired participants were also selected. A
flowchart of exclusion criteria and study timeline is provided in Figure 1. Participants
missing essential covariates (i.e., demographic variables, APOEε4 status, and
cardiovascular risk factors) were excluded from the analysis. A subset of participants (N
= 6) who completed MRI but did not have complete DTI data were excluded from this
portion of analysis.
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Frailty assessment
Participants who attended Visits 5, 6, and 7 of the ARIC Neurocognitive Study
(NCS) were categorized as frail, pre-frail, or robust based on the frailty phenotype
definition operationalized by the Cardiovascular Health Study (CHS) (Fried et al., 2001)
and validated within this population (Kucharska-Newton et al., 2017). This definition of
frailty is based on 5 components: exhaustion, low physical activity, slowness, unintended
weight loss, and weakness.
At Visit 5, exhaustion was defined as responses to two questions from the Center
for Epidemiological Study’s-Depression (CES-D) scale (Radloff, 1977); as the lowest
quintile of level of sport activity in leisure time from the Baecke physical activity
questionnaire; slowness as 4m walking speed within the lowest 20th percentile, adjusted
for sex and height; weight loss as >10% lb decrease from Visit 4 (occurred in midlife) to
Visit 5, a body mass index (BMI) at Visit 5 less than 18.5kg/m2 (Visit 5); and weakness
as grip strength in the lowest 20th percentile, adjusting for sex and BMI. Follow-up frailty
assessment was obtained at Visit 6 and/or Visit 7. In the event that participants had
complete frailty assessment data for both Visits 6 and 7, Visit 7 data were used. At Visits
6 and 7, exhaustion was defined as responses to two questions from the Center for
Epidemiological Study’s-Depression (CES-D) scale (Radloff, 1977); low physical
activity as the lowest quintile of level of sport activity in leisure time from the Baecke
physical activity questionnaire; weight loss as > 5% weight loss from Visit 5 to 6 or 6 to
7 or BMI at Visit 6 or 7 less than 18.5 kg/m2; and grip strength as the lowest 20th
percentile adjusted for sex and BMI. To reflect the changing age demographic of
participants from Visit 5 (midlife) to Visits 6 and 7 (older adulthood), the weight loss
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component of the frailty assessment was adjusted from >10% at Visit 5 to >5% at Visits
6 and 7. Participants were categorized as frail if they met 3 or more of the criteria listed
above. Otherwise, participants were classified as non-frail.
Dementia classification
Cognitive classification was conducted by expert adjudications based on National
Institute on Aging-Alzheimer’s Association (NIA-AA) and Diagnostic and Statistical
Manual for Mental Disorders, 5th Edition criteria (American Psychiatric Association,
2013). More specifically, mild cognitive impairment (MCI) and dementia at Visit 5 were
classified by an expert panel of adjudicators according to National Institute on AgingAlzheimer’s Association (NIA-AA) workgroup and Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition (DSM-5) criteria (Albert et al., 2011; American Psychiatric
Association, 2013; McKhann et al., 2011). Assessment included a comprehensive battery
of cognitive tests administered at ARIC visits, 2, 4, and 5, informant interview conducted
at Visit 5 which included the Clinical Dementia Rating Scale (CDR) and Functional
Activities Questionnaire (FAQ). MCI was defined as one or more cognitive domain score
1.5 SD below normative mean, CDR score between >0.5 and ≤3, FAQ score ≤5, and
decline on the ARIC repeated cognitive battery below 10th percentile on one test or 20th
percentile on two tests (Knopman et al., 2016). Dementia was defined as two or more
cognitive domain scores 1.5 SD below normative mean, CDR score >3 or FAQ >5, and
decline on the ARIC repeated cognitive battery below 10th percentile on one test or 20th
percentile on two tests (McKhann et al., 2011). Participants who did not meet criteria for
MCI or dementia were classified as cognitively normal.
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Brain MRI
Brain MRIs were conducted with a 3T MRI scanner. Acquisition details have
been described previously (Knopman et al., 2015). All images were analyzed with a
common set of sequences: MP-RAGE, Axial T2*GRE, Axial T2 FLAIR, and Axial
diffusion tensor imaging (DTI). WMH volume (mm3) was derived from T2 FLAIR
images using a computer-aided segmentation program (FLAIR-histoseg) to measure the
total volumetric burden (Raz et al., 2013). WMH volumes were log transformed due to
skewness.
White matter fractional anisotropy (FA) and mean diffusivity (MD) were
measured using DTI, as described previously (Power et al., 2017). Lower FA and higher
MD values are an indicator of poorer white matter microstructural integrity. For primary
analyses, composite FA and MD values were generated from a representative sample of
projection, commissural, and association tracts implicated in frailty in existing literature:
the superior longitudinal fasiculus, posterior limb of the internal capsule, as well as the
genu, body, and splenium of the corpus callosum (Avila-Funes et al., 2017; Maltais et al.,
2020). General factors for FA (gFA) and MD (gMD) were derived from the first
unrotated principal component of the standardized FA and MD values from the
aforementioned white matter tracts as summarized in Table 1.
Covariate and clinical assessment
Participant demographic (i.e., age, race, education, sex, center) data were obtained
at ARIC Visit 1 based on self-report. All other covariates were defined at Visit 5. BMI
kg/m2 was defined by participant measured height and weight. Participants were
classified as hypertensive if their mean of the second and third of three blood pressure
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measurements were ≥140 for systolic blood pressure, ≥ 90 mm diastolic blood pressure,
or used antihypertensive medications. Diabetes was defined as presence of hemoglobin
A1C levels ≥6.5%, use of medication for diabetes, or self-reported history of diabetes.
History of coronary artery disease was defined as self-report at Visit 1 or adjudicated
events between Visits 1 and 5. Smoking status was defined based on self-reported current
tobacco use. The TaqMan assay (Applied Biosystems, Foster City, California) was used
to measure APOE genotype (0 vs. ≥1 APOEε4 alleles). Given the uneven sampling
distribution of race groups across sites and potential influence of geographic regions on
participant characteristics, a combined race-center variable a combined race-center
variable was used as a covariate in analyses. There were five race-center groups included
in analyses: Black from Jackson, MS; Black from Forsyth County, NC; White from
Washington County, MD; White from Forsyth County, NC; and White from
Minneapolis, MN.
Data analysis
Chi square and independent sample t-tests were used to compare participant demographic
and clinical characteristics for categorical and continuous variables, respectively.
Categorical variables were dummy coded. Separate multivariable linear regression
models to examine the cross-sectional associations between measures of white matter
integrity (i.e., WMH volume, gFA, and gMD) and frailty status in order to derive beta
estimates for neuroimaging variables and to be consistent with the existing literature.
Three models were assessed: an unadjusted model (Model 1), a model adjusting for
potentially confounding demographic variables (i.e., age, education, sex, race-center, and
APOEe4 status) (Model 2), and a third model which additionally adjusted for the effects
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of cardiovascular risk factors (i.e., BMI, hypertension, diabetes, coronary heart disease,
and smoking status) (Model 3). Analyses examining WMH also adjusted for intracranial
volume. Given that follow-up neuroimaging data were not available for review and in
order to be consistent with the existing literature, separate multivariable logistic
regression models were used to examine the cross-temporal association of WMH volume,
gFA, and gMD with incident frailty. Analyses were adjusted for demographic and clinical
characteristics as described in Models 1-3.
Several secondary/sensitivity analyses were conducted. First, analyses were
conducted without participants with known history of stroke, dementia, or MCI
confirmed by the end of Visit 5. Second, sampling weights were incorporated to account
for the ARIC Visit 5 MRI sampling strategy as has been previously described in the
literature (Gottesman et al., 2014). Third, DTI analyses were repeated including WMH
volume and estimated intracranial volume as covariates. Fourth, effect moderation by
race and sex was examined using multiplicative interaction terms followed by stratified
analyses. Lastly, as part of a post-hoc exploratory analyses, DTI analyses were repeated
examining many individual white matter tracts associated with frailty in the existing
literature. The false discovery rate correction was applied to account for multiple
comparisons.
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Results
A total of 1,754 participants were included in the analysis (mean age = 76.2 years,
SD = 5.2 years; 59.4% female, 29.1% Black) with 1,625 (92.6%) classified as non-frail
and 129 (7.4%) as frail at Visit 5. Compared to non-frail participants, those classified as
frail were older, had less education, and greater prevalence of diabetes and coronary
artery disease. Full sample characteristics are summarized in Table 2. Relative to those
included in the cross-temporal analysis, participants who did not return for follow-up
frailty assessment at either Visit 6 or 7 were younger, more likely to be White, less
educated, and less likely to have one or more APOEε4 allele (Table 3). Incident frailty
analyses were limited to 1,379 participants non-frail at baseline with available MRI data
and frailty follow-up assessments at either Visit 6 or Visit 7.
Cross-sectional association of frailty and white matter structure
Compared to non-frail participants, individuals with frailty demonstrated greater
WMH volume in an unadjusted model, after adjusting for demographic characteristics
(Table 4), and after additionally adjusting for cardiovascular risk factors (Table 4). In the
fully adjusted model, frailty was associated with a 0.29 SD greater WMH volume (95%
CI: 0.13, 0.45; p <0.001). This relationship was maintained when excluding participants
with history of stroke and dementia. However, this relationship did not persist when
analyses were restricted to cognitively normal participants (i.e., the group of participants
without MCI or dementia; Table 5).
Examination of DTI measures of white matter microstructural integrity yielded
similar results. Frailty status, compared to non-frail, was associated with lower gFA and
greater gMD in an unadjusted model, after adjusting for demographic characteristics, and
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after additionally adjusting for cardiovascular risk factors (Table 5). Results were similar
when participants with confirmed history of stroke or dementia were excluded. Among
cognitively normal participants, only gMD was associated with frailty status (Table 5).
Given the robust association between frailty status and WMH volume, analyses of DTI
measures with WMH volume as a covariate were performed. Results are summarized in
Table 6. gFA was associated with physical frailty in all groups, with the exception of the
cognitively normal subgroup. The relationship between physical frailty and gMD
remained statistically significant across groups when adjusting for WMH volume.
Cross-temporal association of white matter structure and frailty risk
Among the 1,379 non-frail participants with available brain MRI data at ARIC
visit 5, 270 developed incident frailty at either Visit 6 or 7. Median follow-up time from
Visit 5 to Visit 6 was 4.9 years, and 6.6 years from Visit 5 to Visit 7. Non-frail
participants who dropped out before the first follow-up visit were more likely to be White
and less educated; however, groups did not differ in terms of health or cognitive
characteristics (Table 3). Presence of cognitive impairment (i.e., MCI/dementia) did not
differ between participants who completed follow-up frailty assessment as compared to
those who did not (Table 3).
WMH volume at Visit 5 alone was not associated with future frailty (Table 7,
Model 1). However, when demographic covariates were included, there was an apparent
relationship between increased WMH volume and future frailty (Table 7, Model 2). In
the fully adjusted model, greater WMH volume at Visit 5 was associated with increased
odds of frailty at a future visit (either 6 or 7; OR = 1.47 per SD increase in WMH
volume; 95% CI: 1.12, 1.86; p = 0.002) (Table 8). The relationship between greater
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WMH volume and incident frailty was similar when participants with baseline stroke and
dementia were excluded. Among cognitively normal participants, each SD higher WMH
volume was associated with nearly 80% increased odds of incident frailty (OR = 1.77;
95% CI: 1.24, 2.399; p = 0.001).
Although gFA and gMD were associated with incident frailty in the unadjusted
model, this association was attenuated and non-significant with the addition of
demographic covariates (Table 7, Models 1 and 2). There was no significant association
between either gFA or gMD and frailty incidence in the fully adjusted model.
Surprisingly, after adjusting for WMH volume, lower gMD was associated with greater
odds of incident frailty across participant groups (Table 9). Inclusion of WMH volume in
gFA models did not change these results.
Secondary and post-hoc analyses
Across analyses there was no evidence of effect modification by race and sex.
Primary results were similar when incorporating sampling weights to account for
inclusion into the MRI study (Table 10). The association between FA and MD values
was examined with the individual tracts used to generate factor scores which are
summarized in Figure 2. In cross-sectional analyses, frailty was associated with lower
FA of the corpus callosum and higher MD of the body of the corpus callosum, as well as
the right and left posterior limb of the internal capsule and superior longitudinal fasiculus.
Interestingly, frailty prevalence was associated with lower MD in the splenium and genu
of the corpus callosum. However, these associations were not significant in crosstemporal analyses.
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As part of an exploratory hypothesis-generating analysis, we examined the
association between frailty and a broader selection of white matter tracts which have been
implicated in frailty in the existing literature: the uncinate fasiculus, external capsule,
superior fronto-occipital fasiculus, hippocampal cingulate, cingulate, posterior corona
radiata, superior corona radiate, posterior thalamic radiation, and anterior limb of the
internal capsule. There was a similar pattern of results observed in the main findings
(Figure 3). Briefly, frailty prevalence was associated with lower FA of the left uncinate
fasiculus and cingulum hippocampus, as well as the external capsule, superior frontooccipital fasiculus, cingulum cingulate, posterior thalamic radiation, and anterior limb of
the internal capsule bilaterally (Figure 3, Part A). Additionally, frailty was associated
with higher MD across all tracts, apart from the aforementioned splenium and genu.
Cross-temporally, results were generally nonsignificant (Figure 3, Part B). MD values of
the tracts examined was not associated with frailty incidence. However, lower FA values
of the bilateral posterior and superior corona radiata, as well as the anterior limb of the
internal capsule, were associated with future frailty.
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Discussion
Using a community-based study of older adults, the current study demonstrates
that individuals with physical frailty have greater WMH volume and white matter
structural abnormalities than do non-frail individuals. Importantly, this relationship was
observed in participants without history of stroke or dementia, but did not persist when
analyses were restricted to cognitively normal individuals. Furthermore, among non-frail
individuals, WMH volume was significantly associated with 4-7-year frailty risk, even
among cognitively normal adults. These results were consistent in Black and White
participants, and in men and women. Unlike WMH volume, general measures of white
matter microstructural integrity were not associated with risk of future frailty.
There is growing evidence to suggest a relationship between frailty, as well as it’s
individual components, and white matter changes cross-sectionally (Kant et al., 2019;
López-Sanz et al., 2018; Siejka et al., 2018). White matter abnormalities have also been
associated with progression of frailty components over time (Maltais et al., 2020; Siejka
et al., 2020; Sullivan et al., 2021). ). However, the literature that has examined the
relationship between structural indicators of neurological health and frailty risk to date
has been largely limited by modest sample sizes, a lack of inclusion of participants across
the robust-to-frailty spectrum, and a lack of racial diversity.
By comparison, the present study assessed the cross-sectional and cross-temporal
link between macrostructural and microstructural white matter integrity in a multiracial
community-based cohort and found that macrostructural abnormalities in white matter are
more severe in those older adults who will go on to develop frailty. This link between
WMH and incident frailty, which was especially strong even among cognitively normal
older adults, suggests that declining cerebrovascular health may be a risk factor for the
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decline of multiple physiologic systems (i.e., frailty) even outside the context of clinically
significant cognitive impairment or dementia.
Few studies have examined white matter microstructural integrity and physical
frailty, particularly with regard to frailty incidence. Cross-sectional studies have
demonstrated associations between poorer white matter microstructural integrity of
specific white matter tracts (i.e., internal capsule, external capsule, posterior thalamic
radiation, and corpus callosum) and frailty (Avila-Funes et al., 2017; Tian et al., 2020).
To date, one study has examined the relationship between white matter microstructural
integrity and progression of frailty symptoms. After adjustment for multiple comparison,
this investigation demonstrated a relationship between higher baseline MD values of
specific tracts (i.e., internal capsule, external capsule, posterior and superior corona
radiata, posterior thalamic radiation, superior fronto-occipital fasiculus, and superior
longitudinal fasiculus) and progression of frailty symptoms (Maltais et al., 2020).
However, there was no association between FA values and frailty progression.
Results from the present analyses, which suggests a link between WMH volume,
but not overall measures of FA/MD, and future frailty, support the notion that WMHs are
an indicator of more severe white matter damage, compared to DTI microstructural
measures. In general, there is evidence supporting the idea that WM microstructural
integrity is less predictive of potential negative health outcomes among older adults
relative to more severe structural abnormalities (Power et al., 2019; Scott et al., 2020).
Although WM microstructural integrity is associated with cognition, including cognitive
domain scores, MCI and dementia status, in older adults cross-sectionally, these
relationships appear to generally attenuate over time. While both general and tract-
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specific DTI measures were not consistently or strongly associated with incident frailty in
these analyses, the few statistically significant tract-specific findings derived from
secondary analyses may contribute to our understanding of frailty risk. Specifically, we
found that the FA of multiple tracts, including the anterior limb of the internal capsule,
superior corona radiata, and posterior corona radiata, was associated with progression
from non-frail to frail status. However, these findings did not extend to measures of MD,
or to other white matter tracts that have been associated with prevalent frailty previously.
These varying tract-specific associations with incident frailty suggest a differential
contribution of specific white matter tracts – in this case, afferent projection fibers – to
frailty development. However, these findings may also be explained by white matter
tract-specific associations with motor control components of frailty (i.e., grip strength and
gait speed), rather than frailty as a syndrome.
Taken together, our primary results suggest that for white matter structural
abnormalities to increase frailty risk, alterations must be severe enough to manifest as
macroscopic changes visible on FLAIR MRI. Thus, relative to macrostructural changes,
white matter altered at the microstructural level does not appear to be a robust frailty risk
factor. In general, there is evidence supporting the idea that white matter microstructural
alterations are less predictive of potential negative health outcomes among older adults
relative to more severe structural abnormalities. Although white matter microstructural
properties are associated with cognitive outcomes in older adults, these relationships
appear to attenuate over time (Power et al., 2019; Scott et al., 2020). Physical frailty and
cognitive decline can occur independent of one another, however, there is often overlap
between these syndromes which suggests some common underlying neurobiological
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pathways. The degree to which such attenuation can be explained by limited follow-up
for a less severe manifestation of a pathological change merits further study.
Our investigation found no effect moderation by race or sex. Although physical
frailty is generally more prevalent among Black identifying individuals and women, we
did not observe an interaction between self-identified race and frailty (Hirsch et al.,
2006). There are some characteristics of our sample which may explain the lack of
observed association in the current analyses. Frailty prevalence at Visit 5 did not differ
significantly among Black and White participants within our study sample. However,
there were group differences in other characteristics which have been implicated in frailty
pathogenesis, namely age, cardiovascular disease, and cognitive status. These other
factors appear to have had a greater relative contribution to frailty prevalence and
incidence than race alone. Although prevalence rates of frailty may vary across racial
ethnic groups, this observed difference may not necessarily be associated with effect
moderation. To elaborate, frailty prevalence may be increased among Black as opposed
to White populations. However, the underlying mechanisms associated with frailty are
likely governed by white matter pathology as opposed to racial/ethnic identity in and of
itself. Furthermore, the existing literature suggests that the increased prevalence of frailty
among racial/ethnic minorities may be better explained by psychosocial and medical
stressors frequently associated with health disparities.
The observational nature of this study prohibits causal inferences. However, one
possible mechanism for these changes is shared or overlapping causes of physical frailty
and cerebral white matter changes. The present findings suggest that volume of WMH
may be an important marker of frailty risk. One possible mechanism for these changes is
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inflammation. Although there has been conflicting results regarding frailty and
inflammation, there is compelling evidence to suggest that chronic inflammation
sustained during midlife is associated with frailty incidence. Furthermore, midlife
inflammation may precipitate changes in cerebral white matter, which could suggest that
WMH volume mediates the relationship between inflammation and frailty (Soysal et al.,
2016; Walker et al., 2018, 2019). Another potential contribution is caridiovascular
disease and impaired hemostasis are associated with frailty incidence (Afilalo et al.,
2009; Kanapuru & Ershler, 2009; Walker et al., 2019). Each of these factors, that is
systemic inflammation, cardiovascular disease and impaired hemostatsis have also been
consistently associated with WMH volume and white matter structural integrity (Markus
et al., 2005; Power et al., 2017; Soysal et al., 2016; Walker et al., 2018).
Physical frailty may clinically represent the early stages of a neurodegenerative
process affecting white matter structure. Indeed, frailty is conceptualized as a syndrome
representing decline across multiple physiologic systems, including neurologic
functioning and there is increasing evidence that frailty is an early indication of cognitive
and functional decline (Borges et al., 2019; Fried et al., 2001). Frailty has been
established as a risk factor for cognitive decline and specifically Vascular dementia
(VaD) (Avila-Funes et al., 2012; Solfrizzi et al., 2013). Although white matter disease is
frequently associated with VaD, changes to the cerebrovasculature and white matter
properties are prevalent across neurodegenerative conditions (Sweeney et al., 2018). Our
findings suggest that WMH volume and microstructural integrity of specific afferent
projection fibers contribute to future frailty, even among individuals who do not
demonstrate cognitive decline. Previous studies have noted changes in grey matter among
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individuals with physical frailty, as well as individual frailty components (W.-T. Chen et
al., 2015; Nishita et al., 2019). However, the relationship between grey and white matter
changes in the development of frailty remains unclear.
There are several notable strengths of the current analysis including a large
community-based cohort, a racially and geographically diverse sample, the prospective
study design, and investigation of frailty incidence, as opposed to progression of
symptoms. However, there are several limitations which warrant further discussion. First,
risk factors for sensitivity groups (i.e., individuals with history of stroke, dementia, or
MCI) were assessed only at baseline. Although the cross-sectional associations between
frailty and WMH volume were largely statistically significant, it is possible that
development of stroke or cognitive impairment may explain the observed relationship
between WMH and incident frailty. Second, follow-up MRI data for participants was not
available concurrently with follow-up frailty status. Therefore, it was not possible to
examine the frailty – WMH volume relationship bidirectionally. While the results from
the present analysis suggest a strong relationship between frailty incidence and WMH
volume, it is unclear from the current results if physical frailty is associated with
progression of white matter abnormalities. Due to the observational nature of this study,
determination of whether the link between frailty and white matter changes are due to
frailty itself, or its associated comorbidities is not possible. Despite adjustment for several
baseline cardiovascular risk factors and physiological measures, the possibility that the
observed effects are driven by separate clinical or subclinical variables which have not
been accounted for cannot be excluded based on the present analysis. Lastly, differential
attrition of participants after the baseline visit may have biased our analysis of frailty risk.

20

However, we found minimal difference between participants who did and did not attend
follow-up on the characteristics most strongly associated with frailty risk. Future research
is needed to further examine the potential cyclical relationship between frailty and
associated health comorbidities in order to establish whether frailty in and of itself
contributes to neurobiological changes, which may in turn reinforce negative health
outcomes.
In summary, the current study suggests that individuals who are physically frail
tend to have greater white matter structural abnormalities, even among those without
dementia. Moreover, WMH, but not white matter microstructural integrity, may be an
important marker of frailty risk, particularly among cognitively normal individuals.
Based on the results of the current analyses, frail individuals could be considered at risk
for white matter pathology. As such, development of physical frailty may serve as an
early indication of dementia or cognitive deterioration, such as depression or decline in
functional abilities. Implementation of frailty assessment in healthcare settings may be
helpful in identifying individuals at risk for cognitive and functional decline.
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Figure 1. Study Design

Abbreviations: ARIC, Atherosclerosis Risk in Communities; MRI, Magnetic Resonance
Imaging.
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Table 1. Principal component analysis (PCA) for white matter tracts included in general
FA (gFA) and MD (gMD) composite scores.
White matter tract
Superior Longitudinal Fasciculus, Left
Superior Longitudinal Fasciculus, Right
Posterior Limb of Internal Capsule, Left
Posterior Limb of Internal Capsule, Right
Genu of the Corpus Callosum
Body of the Corpus Callosum
Splenium of the Corpus Callosum
Eigenvalue
Proportion of variance

PC1 (gFA)
0.76
0.77
0.66
0.61
0.59
0.56
0.49
2.88
41.19%

PC1 (gMD)
0.86
0.88
0.79
0.81
0.74
0.78
0.83
4.64
66.30%

Factor scores for gFA and gMD are derived from these principal component analyses
capture the shared variance in white matter integrity across multiple white matter tracts.
Abbreviations: gFA. general fractional anisotropy; gMD, general mean diffusivity.
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Table 2. Baseline demographic and clinical characteristics stratified by frailty status.
Characteristics
Age a
Female Sex (n%) b
Black (n%)
White (n%)
Level of education (n%) a
Less than high school
High school/
GED/vocational
College/graduate/
professional
APOE e4 alleles (n%)
0 e4 alleles
1 e4 alleles
2 e4 alleles
BMI
Hypertension (n%) b
Coronary Artery Disease
(n%) a
Diabetes (n%) a
Current Smoking (n%)
Stroke (n%)
Cognitive Status (n%) a
Normal
MCI
Dementia

Total
(N =1,754)
76.2 (5.2)
1,041 (59.4)
510 (29.1)
1,244 (70.9)

Non-frail
(N = 1,625)
76.0 (4.7)
954 (58.7)
473 (29.1)
1,152 (70.9)

Frail
(N = 129)
78.5 (5.5)
87 (67.4)
37 (28.7)
92 (71.3)

247 (14.1)
713 (40.6)

217 (13.4)
657 (40.4)

30 (25.6)
56 (43.4)

794 (45.3)

751 (46.2)

43 (33.3)

1,248 (70.8)
460 (26.2)
46 (2.6)
28.4 (5.6)
1,314 (74.9)
184 (10.5)

524 (32.2)
188 (11.6)
21 (1.3)
28.4 (5.2)
1,209 (74.4)
163 (10.0)

87 (67.4)
33 (25.6)
4 (3.1)
28.8 (6.8)
105 (81.4)
21 (16.3)

540 (30.8)
90 (5.1)
59 (3.4)

488 (30.0)
81 (5.0)
18 (1.1)

52 (9.6)
9 (7.0)
7 (5.4)

1,079 (61.6)
581 (33.2)
92 (5.3)

1,023 (63.0)
523 (32.2)
77 (4.7)

56 (43.4)
58 (45.0)
15 (11.6)

Values are represented as mean (standard deviation) for continuous variables and
frequency (percentage of sample) for categorical variables. One way analysis of variance
were used for continuous variables and chi-square for categorical variables.
Abbreviations: BMI, body mass index; MCI, Mild Cognitive Impairment.

a

P ≤0.05 Difference between frail and non-frail participants.

b

P <0.10 Difference between frail and non-frail participants.
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Table 3. Participant characteristics stratified by inclusion in cross-temporal analyses,
excluding participants classified as frail at Visit 5.
Characteristics
Age a
Female Sex
Black a
White a
Level of education a
Less than high school
High school/GED/vocational
College/graduate/professional
APOE e4 alleles a
0 e4 alleles
1 e4 alleles
2 e4 alleles
BMI
Hypertension
Coronary Artery Disease
Diabetes
Current Smoking
Stroke
Cognitive Status
Normal
MCI
Dementia

Total Baseline
MRI
(N = 1,737)
76.1 (5.2)
1,019 (58.7)
503 (29.0)
1,230 (70.8)

Non Crosstemporal Sample
(N = 258)
75.2 (5.2)
163 (63.2)
3 (0.<1)
252 (99.9)

Cross-temporal
MRI Sample
(N = 1,379)
76.1 (5.2)
803 (58.2)
473 (34.3)
906 (65.7)

235 (13.5)
700 (40.3)
800 (46.1)

37 (14.3)
142 (55.0)
79 (30.6)

183 (13.3)
523 (37.9)
673 (48.8)

1,189 (68.5)
445 (25.6)
43 (2.5)
28.5 (5.5)
1,281 (73.7)
177 (1.1)
523 (30.1)
90 (5.2)
53 (3.1)

187 (72.5)
60 (23.3)
4 (< 0.1)
28.9 (5.7)
184 (71.3)
25 (9.7)
85 (32.9)
11 (4.3)
5 (< 0.1)

973 (70.6)
368 (26.7)
38 (2.8)
28.3 (5.5)
1,030 (74.7)
136 (9.9)
404 (29.3)
71 (5.1)
46 (3.3)

1,083 (62.3)
567 (32.6)
85 (4.9)

153 (59.3)
93 (36.0)
12 (< 0.1)

875 (63.5)
434 (31.5)
68 (4.9)

Values are represented as mean (standard deviation) for continuous variables and
frequency (percentage of sample) for categorical variables. Independent sample t-tests
were used for continuous variables and chi-square for categorical variables.
Abbreviations: BMI, body mass index; MCI, Mild Cognitive Impairment.

a

P ≤0.05 Difference between cross-temporal and non-cross-temporal participants.
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Table 4. Cross-sectional study sample associations between frailty status and white
matter structure using alternative models.
MRI
Characteristics

WMH volume
gFA
gMD

Model 1
N = 1,870
ß
P
(95% CI)
0.52 (0.36,
<0.001
0.69)
-0.49 (-0.65, <0.001
0.32)
0.59 (0.43,
<0.001
0.75)

Model 2
N = 1,791
ß
P
(95% CI)
0.31 (0.15,
<0.001
0.47)
-0.35 (-0.52, <0.001
0.19)
0.46 (0.31,
<0.001
0.60)

Model 1 is adjusted for intracranial volume. Model 2 is additionally adjusted for age,
center, race, sex, education, and APOE ε4 status. Seventy-nine participants included in
model 1 were excluded from model 2 due to missing one or more model 2 covariate.
Values represent the adjusted difference in standardized WMH volume, gFA, and gMD
between the frail and non-frail group. Abbreviations: ß, standardized beta coefficient,
BMI, body mass index; gFA. general fractional anisotropy; gMD, general mean
diffusivity; OR, odds ratio; WMH, white matter hyperintensity. Characteristic
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Table 5. Cross-sectional associations between frailty status and white matter structure.
MRI
Characteristics

WMH volume
gFA

Total

No prior stroke

Non-demented

N = 1,748
ß (95% CI)

N = 1,689
ß (95% CI)

N = 1,653
ß (95% CI)

Cognitively
normal
N = 1,076
ß (95% CI)

0.29
(0.13, 0.45) a
-0.31
(-0.47, -0.14)

0.26
(0.10, 0.43) b
-0.27
(-0.44, -0.11) a

0.28
(0.11, 0.45) a
-0.33
(-0.50, -0.16) a

0.05
(-0.19, 0.29)
-0.20
(-0.43, 0.03)

0.43
(0.29, 0.58) a

0.41
(0.27, 0.56) a

0.40
(0.25, 0.55) a

0.29
(0.09, 0.49) b

a

gMD

Models are adjusted for age, sex, race-center, education, APOE ε4 status, BMI,
hypertension, coronary artery disease, diabetes, and cigarette use status obtained at the
time of neuroimaging. Values represent the adjusted difference in standardized WMH
volume, gFA, and gMD between the frail and non-frail group.
Abbreviations: ß, standardized beta coefficient; BMI, body mass index; gFA, general
fractional anisotropy; gMD, general mean diffusivity; WMH, white matter
hyperintensity.

a

Results significant at the p ≤ 0.001 level.

b

Results significant at the p <0.05 level.
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Table 6. Cross-sectional associations between frailty status and white matter
microstructural integrity, adjusted for white matter hyperintensity volume.
MRI
Characteristics

All
participants

No prior stroke

Non-demented

N = 1,669

N = 1,639

Cognitively
Normal
N = 1,069

ß

ß

ß

ß

(95% CI)
-0.26
(-0.40, -0.11)

(95% CI)
-0.23
(-0.38, -0.08) b

(95% CI)
-0.26
(-0.42, -0.33) a

(95% CI)
-0.20
(-0.41, 0.01)

0.32
(0.19, 0.45) a

0.30
(0.17, 0.43) a

0.31
(0.17, 0.44) a

0.26
(0.08, 0.44) b

N = 1,726

gFA

a

gMD

Models are adjusted for age, sex, race-center, education, APOE, BMI, hypertension,
coronary artery disease, diabetes, cigarette use, WMH volume, and estimated intracranial
volume obtained at the time of neuroimaging. Values represent the adjusted difference in
standardized gFA, and gMD between the frail and non-frail group.
Abbreviations: B, unstandardized beta coefficient; BMI, body mass index; gFA. general
fractional anisotropy; gMD, general mean diffusivity; WMH, white matter
hyperintensity.

a

Results significant at the P ≤ 0.001 level.

b

Results significant at the P <0.05 level.
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Table 7. Associations between white matter structure and future frailty using alternative
models.
MRI
Characteristics

WMH volume
gFA
gMD

Model 1
N= 1,472
OR
P
(95% CI)
1.08
0.33
(0.93, 1.25)
0.58
≤0.001
(0.50, 0.67)
2.47
≤0.001
(2.09, 2.92)

Model 2
N=1,413
OR
(95% CI)
1.43
(1.13, 1.81)
0.86
(0.70, 1.06)
0.91
(0.71, 1.16)

P
≤0.01
0.15
0.43

Model 1 is adjusted for intracranial volume. Model 2 is additionally adjusted for age,
center, race, sex, education, and APOE ε4 status. Values represent the odds of incident
frailty per one unit increase in standardized WMH volume, gFA, and gMD. Fifty-nine
participants included in model 1 were excluded from model 2 due to missing one or more
model 2 covariate.
Abbreviations: BMI, body mass index; gFA. general fractional anisotropy; gMD, general
mean diffusivity; OR, odds ratio; WMH, white matter hyperintensity.
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Table 8. Associations between white matter structure and future frailty.
MRI Characteristics

WMH
volume
gFA
gMD

All participants

No prior stroke

Non-demented

N = 1,379
OR
(95% CI)
1.46
(1.15, 1.87) b
0.84
(0.67, 1.04)
0.93
(0.72, 1.20)

N = 1,333
OR
(95% CI)
1.51
(1.17, 1.94) a
0.83
(0.66, 1.05)
0.89
(0.68, 1.18)

N = 1,309
OR
(95% CI)
1.52
(1.21, 2,01) a
0.84
(0.66, 1.04)
0.92
(0.71, 1.20)

Cognitively
Normal
N = 875
OR
(95% CI)
1.78
(1.26, 2.51) a
0.95
(0.68, 1.3)
0.78
(0.53, 1.14)

Models are adjusted for age, sex, race-center, education, APOE ε4 status, BMI,
hypertension, coronary artery disease, diabetes, cigarette use, stroke, and cognitive status
obtained at the time of neuroimaging. Values represent the odds of incident frailty per
one unit increase in standardized WMH volume, gFA, and gMD.
Abbreviations: BMI, body mass index; gFA, general fractional anisotropy; gMD, general
mean diffusivity; OR, odds ratio.

a

Results significant at the p ≤ 0.001 level.

b

Results significant at the p <0.05 level.
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Table 9. Cross-temporal associations between frailty status and white matter
microstructural integrity, adjusted for white matter hyperintensity volume.
MRI
Characteristics

gFA
gMD

All participants

No prior stroke

Non-demented

N = 1,360
OR
(95% CI)
0.96
(0.74, 1.24)
0.82
(0.60, 1.11)

N = 1,315
OR
(95% CI)
0.99
(0.77, 1.29)
0.76
(0.55, 1.04)

N = 1,296
OR
(95% CI)
0.98
(0.75, 1.27)
0.8
(0.58, 1.09)

Cognitively
Normal
N = 869
OR
(95% CI)
1.18
(0.83, 1.68)
0.6
(0.39, 0.92) a

Models are adjusted for age, sex, race-center, education, APOE, BMI, hypertension,
coronary artery disease, diabetes, cigarette use, WMH volume, and estimated intracranial
volume obtained at the time of neuroimaging. Values represent the odds of incident
frailty per one unit change in standardized WMH volume, gFA, and gMD.
Abbreviations: BMI, body mass index; gFA. general fractional anisotropy; gMD, general
mean diffusivity; OR, odds ratio; WMH, white matter hyperintensity.

a

Results significant at the P <0.05 level.
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Table 10. Cross-sectional and cross-temporal associations between frailty status and
white matter structure, after incorporation of ARIC sampling weights.
MRI
Characteristics
WMH Volume
gFA
gMD

Cross-sectional
N = 1,748
B
(95% CI)
0.22
(0.06, 0.38)
-0.31
(-0.51, -0.10)
0.39
(0.24, 0.54)

P
0.009
0.001
<0.001

Cross-temporal
N = 1,379
OR
P
(95% CI)
1.30
0.01
(1.01, 1.63)
0.82
0.227
(0.59, 1.13)
0.99
0.958
(0.68, 1.44)

Models are adjusted for age, sex, race-center, education, APOE ε4 status, BMI,
hypertension, coronary artery disease, diabetes, and cigarette use obtained at the time of
neuroimaging. Cross-sectional values represent the adjusted difference in standardized
WMH volume, gFA, and gMD between the frail and non-frail group. Cross-temporal
values represent the odds of incident frailty per one unit increase in standardized WMH
volume, gFA, and gMD.
Abbreviations: FA, fractional anisotropy; MD, general mean diffusivity; OR, odds ratio;
WMH, white matter hyperintensity.
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Figure 2. Cross-sectional and cross-temporal associations between frailty and tract
specific measures of microstructural integrity.
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All models are adjusted for age, sex, race-center, education, APOE ε4 status, BMI,
hypertension, coronary artery disease, diabetes, and cigarette use status obtained at the
time of neuroimaging. Figure A. represents the adjusted standardized ß coefficient and
95% confidence interval of frailty and FA and MD using linear regression. Figure B.
represents the adjusted OR of future frailty per standard deviation increase in FA and MD
using logistic regression.
Abbreviations: BMI, body mass index; FA, fractional anisotropy; MD, mean diffusivity,
OR, odds ratio.
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Figure 3. Cross-sectional and cross-temporal associations between frailty and tract
specific measures of microstructural integrity by individual tract.
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Models are adjusted for age, sex, race-center, education, APOE ε4 status, BMI,
hypertension, coronary artery disease, diabetes, and cigarette use obtained at the time of
neuroimaging. Figure A. represents the adjusted standardized ß coefficient and 95%
confidence interval of frailty and FA and MD using linear regression and FDR correction.
Figure B. represents the adjusted OR of future frailty per standard deviation increase in
FA and MD using logistic regression. Abbreviations: BMI, body mass index; FA,
fractional anisotropy; FDR, false discovery rate; MD, general mean diffusivity; OR, odds
ratio.
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